NCT02555189 2026-04-22
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression
Thomas Jefferson University
Phase 1/2 Terminated
Clinical Trials
3,459 trialsNCT03436654 2026-04-22
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05155501 2026-04-22
PARTIAL
Weill Medical College of Cornell University
Phase NA Recruiting
NCT06172283 2026-04-22
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
State University of New York at Buffalo
Phase NA Recruiting
NCT04946370 2026-04-21
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Weill Medical College of Cornell University
Phase 1/2 Recruiting
NCT07541066 2026-04-21
Robotic Telesurgery in Urology
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT07541911 2026-04-21
LaserSAFE
University College, London
Phase NA Not yet recruiting
NCT06378866 2026-04-20
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT07126548 2026-04-20
A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
Mayo Clinic
Phase NA Not yet recruiting
NCT07219147 2026-04-20
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
City of Hope Medical Center
Phase 1 Recruiting
NCT05766371 2026-04-17
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 2 Recruiting
NCT07234981 2026-04-17
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
University of Nebraska
Phase 2 Recruiting
NCT07253987 2026-04-17
SURV-QoL
Masaryk Memorial Cancer Institute
Phase NA Recruiting
NCT07535541 2026-04-17
BioWEAR
University of Virginia
Phase NA Not yet recruiting
NCT07535905 2026-04-17
REVIVE
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT06171139 2026-04-16
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
University of California, San Francisco
Phase NA Recruiting
NCT06347705 2026-04-16
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT03821792 2026-04-15
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03935282 2026-04-15
AH-HA
Wake Forest University Health Sciences
Phase NA Completed
NCT04215029 2026-04-15
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04396808 2026-04-15
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
University of Michigan Rogel Cancer Center
Phase NA Active not recruiting
NCT04693377 2026-04-15
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT05047965 2026-04-15
An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT05055843 2026-04-15
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06615752 2026-04-15
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Charles Drew University of Medicine and Science
Phase 1/2 Recruiting
NCT07002320 2026-04-15
ASpiRE
Institute of Cancer Research, United Kingdom
Phase 1/2 Recruiting
NCT07111507 2026-04-15
A Study of Tarlatamab for People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07237269 2026-04-15
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
University of Nebraska
Phase 2 Recruiting
NCT07475533 2026-04-15
Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy
Ankara City Hospital Bilkent
Phase NA Not yet recruiting
NCT01902680 2026-04-14
CURIEFOCALE
Institut Claudius Regaud
Phase 2 Completed
NCT05487846 2026-04-14
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Thomas Jefferson University
Phase NA Recruiting
NCT05960578 2026-04-14
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
University of Washington
Phase 2 Active not recruiting
NCT07225309 2026-04-14
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Not yet recruiting
NCT02346253 2026-04-13
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stanford University
Phase NA Active not recruiting
NCT02772588 2026-04-13
AASUR in High Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04337580 2026-04-13
FASN
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT04842890 2026-04-13
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer
The New York Proton Center
Phase 2 Active not recruiting
NCT05113537 2026-04-13
UPLIFT
University of California, San Francisco
Phase 1/2 Recruiting
NCT05313191 2026-04-13
ReRT
The New York Proton Center
Phase NA Recruiting
NCT05558241 2026-04-13
MUSIC-AS
University of Alberta
Phase NA Recruiting
NCT06434649 2026-04-13
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
First Affiliated Hospital of Fujian Medical University
Phase NA Active not recruiting
NCT06594926 2026-04-13
WOMBAT
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Recruiting
NCT06616155 2026-04-13
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 1/2 Recruiting
NCT07093177 2026-04-13
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
University of Utah
Phase NA Recruiting
NCT07220720 2026-04-13
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
University of Florida
Phase 2 Recruiting
NCT07526545 2026-04-13
UPRISE
University of Michigan Rogel Cancer Center
Phase NA Not yet recruiting
NCT07526675 2026-04-13
Bioblation
Benha University
Phase NA Not yet recruiting
NCT00588185 2026-04-09
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT04985565 2026-04-09
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05710861 2026-04-09
EMERHIT
University Hospital, Bordeaux
Phase NA Recruiting